摘要:
The present invention provides a drug delivery vehicle that can improve the pharmacokinetics of pharmacological agents. The invention relates to a multifunctional carrier capable of delivering a carried material such as a pharmacological agent or genetic material to a recipient. The multifunctional carrier includes a multifunctional core and a plurality of adduct molecules bonded thereto. The molecular carrier has surface functional groups which can be associated with a carried material. The carried material can be associated with the molecular carrier through covalent interactions or ionic interactions. The polyvalent core can be ethylene-diamine tetraacetic acid (EDTA) or succinic acid. The invention also relates to methods for producing and using such molecules.
摘要:
The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.
摘要:
The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.
摘要:
The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.
摘要:
The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.
摘要:
The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.
摘要:
The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.
摘要:
The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.
摘要:
The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.
摘要:
The present invention provides pyridopyrimidinone compounds with desirable biological activity and toxicity profiles for the enhanced treatment and prevention of malaria. The invention also relates to methods of making such molecules.